VNIM
AMAG

Vaughan Nelson Investment Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Vaughan Nelson Investment Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-639,475
Closed -$25.4M – 172
2015
Q3 		$25.4M Buy
639,475
+156,000
+32% +$9.68M 0.36% 119
2015
Q2 		$33.4M Buy
483,475
+5,675
+1% +$357K 0.47% 101
2015
Q1 		$26.1M Sell
477,800
-89,625
-16% -$4.27M 0.4% 109
2014
Q4 		$24.2M Buy
+567,425
New +$20.5M 0.35% 110

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vaughan Nelson Investment Management's AMAG Position: Q4 2015 in Review

Vaughan Nelson Investment Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2015, closing a stake of 639,475 shares — an estimated $25.4M sold.

Vaughan Nelson Investment Management first reported a position in AMAG in Q4 2014 and held it in 4 quarters. The position peaked at $33.4M in Q2 2015. 172 funds tracked by Wall St. Rank hold AMAG as of Q4 2015.

  • Vaughan Nelson Investment Management reported no remaining AMAG Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Vaughan Nelson Investment Management sold 639,475 AMAG Pharmaceuticals shares in Q4 2015, an estimated $25.4M.
  • Vaughan Nelson Investment Management first reported a position in AMAG Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • Vaughan Nelson Investment Management's AMAG Pharmaceuticals position peaked at $33.4M in Q2 2015.
  • 172 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2015.

Based on Vaughan Nelson Investment Management's 13F filing for Q4 2015, filed 2 Feb 2016.